30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

McFarlane Neil F.

Track

Insider profile

McFarlane Neil F.'s trades of Zevra Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-10 2026-02-09
PlS Planned sale
18,288 -26.7%
81.09
US$752,960 		18,288 -26.7% 81.09 US$752,960
2026-02-02 2026-02-02
PrS Proposed sale
54,728
257.23
US$845,692 		54,728 257.23 US$845,692
2026-02-02 2026-02-02
PlS Planned sale
198 -39.8%
477.40
US$1,521,854 		198 -39.8% 477.40 US$1,521,854
2025-10-10 2025-10-10
PrS Proposed sale
19,500
10.82
US$210,990 		19,500 10.82 US$210,990
2025-10-10 2025-10-10
PlS Planned sale
19,500 -8.1%
10.82
US$210,908 		19,500 -8.1% 10.82 US$210,908
2025-02-14 2025-02-14
PlS Planned sale
30,544 -13.8%
8.05
US$245,962 		30,544 -13.8% 8.05 US$245,962
2025-02-14 2025-02-13
PlS Planned sale
61,273 -21.6%
7.86
US$481,428 		61,273 -21.6% 7.86 US$481,428
2025-02-13 2025-02-13
PrS Proposed sale
91,817
7.72
US$708,827 		91,817 7.72 US$708,827
2024-08-12 2024-08-12
PrS Proposed sale
44,365
35.21
US$1,562,312 		44,365 35.21 US$1,562,312
2024-08-09 2024-08-09
PrS Proposed sale
5,000
35.20
US$176,007 		5,000 35.20 US$176,007
2019-05-16 2019-05-16
PlS Planned sale
984 -3.5%
18.71
US$18,411 		984 -3.5% 18.71 US$18,411
2019-05-16 2019-05-15
PlS Planned sale
984 -3.4%
17.78
US$17,496 		984 -3.4% 17.78 US$17,496